Trevi Therapeutics Inc TRVI

NAS: TRVI | ISIN: US89532M1018 17/05/2024

2,770 USD (-2,46%)

(-2,46%) 17/05/2024

Grafiek Trevi Therapeutics Inc

Grafiek Trevi Therapeutics Inc

1 dag1d -2,46%
1 week1w 1,47%
1 maand1m -5,78%
3 maanden3m 1,09%
6 maanden6m 113,08%
1 jaar1j 21,49%
5 jaar5j -69,22%

Trevi Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

9 mei 2024 · Trevi Therapeutics to Participate in Upcoming Conferences · Persbericht

7 mei 2024 · Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates · Persbericht

1 mei 2024 · Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024 · Persbericht

9 april 2024 · Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference · Persbericht

4 april 2024 · Trevi Therapeutics to Participate in Upcoming April Events · Persbericht

2 april 2024 · Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team · Persbericht

20 maart 2024 · Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates · Persbericht

13 maart 2024 · Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024 · Persbericht

28 februari 2024 · Trevi Therapeutics to Participate in Upcoming March Events · Persbericht

6 februari 2024 · Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference · Persbericht

Profiel Trevi Therapeutics Inc

Gezondheidstechnologie

Medicinale en botanische productie

Werknemers: 26

Aandelen Trevi Therapeutics Inc

Beurswaarde: 195,11 miljoen USD

Effecten: 70,44 miljoen

Beta: 0,56

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe